Company intelligence
Grünenthal Group
About Grünenthal Group
Grünenthal is a global leader in pain management and related diseases. As a science-based, fully-integrated pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on working towards our vision of a world free of pain. Grünenthal is headquartered in Aachen, Germany, and has affiliates in 28 countries across Europe, Latin America and the US. Our products are available in approx. 100 countries. In 2025, Grünenthal employed around 4,100 people and achieved revenues of € 1.8 bn. More Information on www.grunenthal.com Jobs & Career: https://careers.grunenthal.com Imprint: https://www.grunenthal.com/imprint Privacy: https://www.grunenthal.com/privacy-statement This company profile is managed by Global Communications. In our commitment to transparency and the principles outlined in our digital ethics charter, Grünenthal wishes to inform you that generative artificial intelligence technologies are occasionally used to enhance content on this channel. Each content piece has been reviewed and edited by a team member before publication to ensure accuracy.
Verified activity
Signals from Grünenthal Group
9 published signals
Presence & Recognition
Grünenthal Group hosted Episode 2 of Beyond the Ache featuring chronic pain patient and advocate Helene Anschütz sharing her experience and how finding a community on Instagram gave her hope.
Reported by Grünenthal Group
Presence & Recognition
Grünenthal Group participated in the World Duchenne Awareness Day theme Access Changes Lives to promote access to care and support for people living with Duchenne and their families.
Reported by Grünenthal Group
Presence & Recognition
Grünenthal Group marks World Duchenne Awareness Day to raise awareness of Duchenne muscular dystrophy.
Reported by Uli Broedl
Presence & Recognition
Grünenthal Group received the Global Excellence Award for its enterprise Data & Analytics project at BIANCA
Reported by Ana Marín
Research & Knowledge
Grünenthal Group has compiled key facts about Duchenne muscular dystrophy on its website to support understanding, awareness and dialogue.
Reported by Grünenthal Group
Research & Knowledge
Grünenthal Group announced that applications for the next EFIC–Grünenthal Grant cycle are closing soon.
Reported by Grünenthal Group
Presence & Recognition
Grünenthal Group featured Pat Furlong, President and Founder of Parent Project Muscular Dystrophy, in an interview to discuss the impact of Duchenne muscular dystrophy on individuals and families.
Reported by Grünenthal Group
Presence & Recognition
Grünenthal Group released the first episode of the new podcast Beyond the Ache featuring Prof. Dr. Heike Rittner discussing chronic pain and pain research.
Reported by Grünenthal Group
Presence & Recognition
Grünenthal Group organized a holiday programme for children in the past two weeks with the new partner pme familienservice.
Reported by Oliver Lamm